Prophylactic treatment of migraine with tolfenamic acid, propranolol and placebo - PubMed (original) (raw)
Clinical Trial
Prophylactic treatment of migraine with tolfenamic acid, propranolol and placebo
B Mikkelsen et al. Acta Neurol Scand. 1986 Apr.
Abstract
In 31 patients with at least 3 migraine attacks per month the prophylactic effect of tolfenamic acid 300 mg/day, propranolol 120 mg/day, and placebo was compared in a randomized double-blind cross-over study. The patients were treated for 12 weeks with each drug, but only the last 11 weeks were used for evaluation. Both tolfenamic acid and propranolol significantly reduced the number of attacks, the total duration of attacks and additional drugs taken when compared with placebo. Tolfenamic acid, but not propranolol, significantly reduced the median intensity of pain and the number of attacks confining the patients to their beds when compared with placebo. Only mild adverse reactions occurred with no significant difference between the drugs. It was concluded that the prophylactic effect of tolfenamic acid 300 mg/day in migraine was at least as good as propranolol 120 mg/day.
Similar articles
- Tolfenamic acid versus propranolol in the prophylactic treatment of migraine.
Kjaersgård Rasmussen MJ, Holt Larsen B, Borg L, Soelberg Sørensen P, Hansen PE. Kjaersgård Rasmussen MJ, et al. Acta Neurol Scand. 1994 Jun;89(6):446-50. doi: 10.1111/j.1600-0404.1994.tb02664.x. Acta Neurol Scand. 1994. PMID: 7976233 Clinical Trial. - Randomized double-blind comparison of tolfenamic acid and paracetamol in migraine.
Larsen BH, Christiansen LV, Andersen B, Olesen J. Larsen BH, et al. Acta Neurol Scand. 1990 May;81(5):464-7. doi: 10.1111/j.1600-0404.1990.tb00996.x. Acta Neurol Scand. 1990. PMID: 2375249 Clinical Trial. - Timolol vs propranolol vs placebo in common migraine prophylaxis: a double-blind multicenter trial.
Tfelt-Hansen P, Standnes B, Kangasneimi P, Hakkarainen H, Olesen J. Tfelt-Hansen P, et al. Acta Neurol Scand. 1984 Jan;69(1):1-8. doi: 10.1111/j.1600-0404.1984.tb07772.x. Acta Neurol Scand. 1984. PMID: 6367336 Clinical Trial. - Tolfenamic acid in acute and prophylactic treatment of migraine: a review.
Hansen PE. Hansen PE. Pharmacol Toxicol. 1994;75 Suppl 2:81-2. doi: 10.1111/j.1600-0773.1994.tb02005.x. Pharmacol Toxicol. 1994. PMID: 7816790 Review. - Migraine prophylactic drugs: proof of efficacy, utilization and cost.
Ramadan NM, Schultz LL, Gilkey SJ. Ramadan NM, et al. Cephalalgia. 1997 Apr;17(2):73-80. doi: 10.1046/j.1468-2982.1997.1702073.x. Cephalalgia. 1997. PMID: 9137841 Review.
Cited by
- European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention - part 4: propranolol.
Versijpt J, Deligianni C, Hussain M, Amin F, Reuter U, Sanchez-Del-Rio M, Uluduz D, Boucherie D, Zeraatkar D, MaassenVanDenBrink A, Sacco S, Lampl C, Gil-Gouveia R. Versijpt J, et al. J Headache Pain. 2024 Jul 24;25(1):119. doi: 10.1186/s10194-024-01826-y. J Headache Pain. 2024. PMID: 39044170 Free PMC article. - CGRP monoclonal antibodies in migraine: an efficacy and tolerability comparison with standard prophylactic drugs.
Vandervorst F, Van Deun L, Van Dycke A, Paemeleire K, Reuter U, Schoenen J, Versijpt J. Vandervorst F, et al. J Headache Pain. 2021 Oct 25;22(1):128. doi: 10.1186/s10194-021-01335-2. J Headache Pain. 2021. PMID: 34696711 Free PMC article. - Beta-blockers for the prevention of headache in adults, a systematic review and meta-analysis.
Jackson JL, Kuriyama A, Kuwatsuka Y, Nickoloff S, Storch D, Jackson W, Zhang ZJ, Hayashino Y. Jackson JL, et al. PLoS One. 2019 Mar 20;14(3):e0212785. doi: 10.1371/journal.pone.0212785. eCollection 2019. PLoS One. 2019. PMID: 30893319 Free PMC article. - Unveiling the relative efficacy, safety and tolerability of prophylactic medications for migraine: pairwise and network-meta analysis.
He A, Song D, Zhang L, Li C. He A, et al. J Headache Pain. 2017 Dec;18(1):26. doi: 10.1186/s10194-017-0720-7. Epub 2017 Feb 20. J Headache Pain. 2017. PMID: 28220376 Free PMC article. - WITHDRAWN: Propranolol for migraine prophylaxis.
Linde K, Rossnagel K. Linde K, et al. Cochrane Database Syst Rev. 2017 Feb 17;2(2):CD003225. doi: 10.1002/14651858.CD003225.pub3. Cochrane Database Syst Rev. 2017. PMID: 28212466 Free PMC article. Updated. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical